After a biopsy comes back positive for prostate cancer, patients and their doctors are often left with a choice between taking a watch-and-wait approach, known as active surveillance, or proceeding with surgery or radiation. And identifying which patients will benefit…
Read More
New study may lead to better treatments for prostate, ovarian, and breast cancers
Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers. Bryce M. Paschal,…
Read More
Thousands of men to trial new home test kit for prostate cancer
Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH). Image Credit: University of East Anglia The…
Read More
Firmagon
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Firmagon® Degarelix (as acetate) Powder and Solvent for Injection, depot Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Firmagon. It…
Read More
Norgesic
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NORGESIC™ Tablets Orphenadrine citrate 35mg & Paracetamol 450mg Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Norgesic tablets. However it…
Read More
Buvidal Monthly
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BUVIDAL® Buprenorphine Consumer Medicine Information Warning: Risk of Serious Harm or Death with Intravenous Administration Serious harm or death could result if administered intravenously. Buvidal Monthly forms…
Read More
Artificial intelligence tool for reading MRI scans could transform prostate cancer surgery and treatment
Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict how likely the disease is to recur following surgical treatment for prostate cancer. The…
Read More
Low risk of cancer spread on active surveillance for early prostate cancer
Men undergoing active surveillance for prostate cancer have very low rates – one percent or less—of cancer spread (metastases) or death from prostate cancer, according to a recent study published in The Journal of Urology, an official journal of the…
Read More
The benefits of a prostate cancer screening tool
Multiparametric magnetic resonance imaging of the prostate (mpMRIp) is a promising tool for diagnosing prostate cancer, and prior to its availability, detection relied on clinical exams and prostate specific antigen screening. In a study published in BJU International, investigators found…
Read More
Immunotherapy offers hope for prostate cancer treatment
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. This is the finding of the long-term analyses of an international phase 3 clinical trial, recently published in the journal European Urology. The…
Read More